ABBVIE INC.

ABBV

AbbVie Inc. (ABBV) is a global biopharmaceutical company founded in 2013 as a spin-off from Abbott Laboratories. It specializes in the research, development, and marketing of innovative medicines across a range of therapeutic areas, including immunology, oncology, virology, and neuroscience. AbbVie is known for its flagship product, Humira, a leading treatment for autoimmune diseases. The company focuses on advancing scientific discoveries to deliver novel therapies and improve patient outcomes worldwide.

$220.18 0.00 (0.00%)

Dividend Yield 3.02%

Payout Frequency Quarterly

Dividend History

🎉 Upcoming Dividend

Investors can expect a dividend payout of $1.73 per share, scheduled to be distributed in 42 days on February 17, 2026

Pay Date	Amount	Ex-Date	Record Date
February 17, 2026	$1.73	2026-01-16	2026-01-16
November 14, 2025	$1.64	2025-10-15	2025-10-15
August 15, 2025	$1.64	2025-07-15	2025-07-15
May 15, 2025	$1.64	2025-04-15	2025-04-15
February 14, 2025	$1.64	2025-01-15	2025-01-15
November 15, 2024	$1.55	2024-10-15	2024-10-15
August 15, 2024	$1.55	2024-07-15	2024-07-15
May 15, 2024	$1.55	2024-04-12	2024-04-15
February 15, 2024	$1.55	2024-01-12	2024-01-16
November 15, 2023	$1.48	2023-10-12	2023-10-13
August 15, 2023	$1.48	2023-07-13	2023-07-14
May 15, 2023	$1.48	2023-04-13	2023-04-14
February 15, 2023	$1.48	2023-01-12	2023-01-13
November 15, 2022	$1.41	2022-10-13	2022-10-14
August 15, 2022	$1.41	2022-07-14	2022-07-15
May 16, 2022	$1.41	2022-04-13	2022-04-15
February 15, 2022	$1.41	2022-01-13	2022-01-14
November 15, 2021	$1.30	2021-10-14	2021-10-15
August 16, 2021	$1.30	2021-07-14	2021-07-15
May 14, 2021	$1.30	2021-04-14	2021-04-15
February 16, 2021	$1.30	2021-01-14	2021-01-15
November 16, 2020	$1.18	2020-10-14	2020-10-15
August 14, 2020	$1.18	2020-07-14	2020-07-15
May 15, 2020	$1.18	2020-04-14	2020-04-15
February 14, 2020	$1.18	2020-01-14	2020-01-15
November 15, 2019	$1.07	2019-10-11	2019-10-15
August 15, 2019	$1.07	2019-07-12	2019-07-15
May 15, 2019	$1.07	2019-04-12	2019-04-15
February 15, 2019	$1.07	2019-01-14	2019-01-15
November 15, 2018	$0.96	2018-10-12	2018-10-15
August 15, 2018	$0.96	2018-07-12	2018-07-13
May 15, 2018	$0.96	2018-04-12	2018-04-13
February 15, 2018	$0.71	2018-01-11	2018-01-12
November 15, 2017	$0.64	2017-10-12	2017-10-13
August 15, 2017	$0.64	2017-07-12	2017-07-14
May 15, 2017	$0.64	2017-04-11	2017-04-13
February 15, 2017	$0.64	2017-01-11	2017-01-13
November 15, 2016	$0.57	2016-10-12	2016-10-14
August 15, 2016	$0.57	2016-07-13	2016-07-15
May 16, 2016	$0.57	2016-04-13	2016-04-15
February 16, 2016	$0.57	2016-01-13	2016-01-15
November 14, 2015	$0.51	2015-10-13	2015-10-15
August 14, 2015	$0.51	2015-07-13	2015-07-15
May 15, 2015	$0.51	2015-04-13	2015-04-15
February 13, 2015	$0.49	2015-01-13	2015-01-15
November 17, 2014	$0.42	2014-10-10	2014-10-15
August 15, 2014	$0.42	2014-07-11	2014-07-15
May 15, 2014	$0.42	2014-04-11	2014-04-15
February 14, 2014	$0.40	2014-01-13	2014-01-15
November 15, 2013	$0.40	2013-10-10	2013-10-15
August 15, 2013	$0.40	2013-07-11	2013-07-15
May 15, 2013	$0.40	2013-04-11	2013-04-15
February 15, 2013	$0.40	2013-01-11	2013-01-15

Dividends Summary

ABBVIE INC. has issued 53 dividend payments over the past 13 years
The most recent dividend was paid 53 days ago, on November 14, 2025
The highest dividend payed out to investors during this period was $1.73 per share
The average dividend paid during this period was $1.02 per share.

Company News

Buying This Healthcare Stock Could Make You a Millionaire Retiree

The Motley Fool • Prosper Junior Bakiny • January 3, 2026

AbbVie (ABBV), a pharmaceutical leader, is highlighted as a potential wealth-building investment for long-term retirement planning. The company's resilient business model, diversified product portfolio including top-selling immunology drugs Skyrizi and Rinvoq, strong dividend program (54 years of consecutive increases), and ability to navigate pa...

Ironwood Finds a New Floor as LINZESS Net Pricing Turns Into a Growth Lever

Investing.com • Timothy Fries • January 2, 2026

Ironwood Pharmaceuticals shares surged 36% on January 2, 2026, after announcing 2026 financial guidance that significantly exceeded Wall Street expectations. The company expects LINZESS U.S. net sales of $1.125-1.175 billion (vs. $860-890M in 2025) and total revenue of $450-475 million (vs. consensus of $319.5M), driven by a strategic list price ...

IRWD

White House Readies Drug Price Deals With AbbVie, Novartis, Roche

Benzinga • Vandana Singh • December 18, 2025

The White House is preparing to announce drug pricing agreements with multiple pharmaceutical companies, aiming to lower prescription drug prices and comply with policy demands from the Trump Administration.

NVS PFE

Women’s Healthcare Market Worth USD 46.76 Billion by 2033 Driven by Rising Demand for Reproductive, Preventive, and Digital Health Solutions – SNS Insider

GlobeNewswire Inc. • Sns Insider • December 14, 2025

The global women's healthcare market is projected to grow from USD 20.20 Billion in 2025 to USD 46.76 Billion by 2033, driven by increasing demand for reproductive health, fertility solutions, digital health, and personalized care services.

MRK PFE

Is Invesco Large Cap Value ETF (PWV) a Strong ETF Right Now?

Zacks Investment Research • Zacks Investment Research • August 6, 2024

The article discusses the Invesco Large Cap Value ETF (PWV), which provides broad exposure to the large-cap value segment of the market. It highlights the fund's investment strategy, performance, and risk profile, as well as compares it to similar ETFs like Schwab U.S. Dividend Equity ETF (SCHD) and Vanguard Value ETF (VTV).

BAC AMGN VTV PWV SCHD